Organon-Teknika begins shipping HTLV-I/II blood screening test, giving Abbott competition.
This article was originally published in The Gray Sheet
ORGANON-TEKNIKA BEGINS SHIPPING VIRONOSTIKA HTLV-I/II BLOOD SCREENING TEST the week of Feb. 9 following the recent approval of a biological license application by FDA. The approval ensures competition for Abbott, the only other company with a licensed HTLV-I/II test, when an FDA policy requiring blood bank testing for both types of human T lymphotrophic virus takes effect Feb. 16.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.